[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Celyad Sa ADR (CYAD)

Celyad Sa ADR (CYAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Celyad Sa ADR RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 BEL

www.celyad.com P: 321-039-4100

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Celyad SA is a biopharmaceutical company. The Company develops and commercializes cell based regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. Celyad SA is based in Mont-Saint-Guibert, Belgium.

Key Statistics

Overview:

Market Capitalization, $K 10,619
Enterprise Value, $K -2,491
Shares Outstanding, K 22,594
Float, K 22,382
% Float 99.06%
Short Volume Ratio 0.20
% of Insider Shareholders 0.94%
% of Institutional Shareholders 29.10%

Financials:

Annual Sales, $ 20 K
Annual Net Income, $ 940 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,483 K

Growth:

1-Year Return -69.68%
3-Year Return -94.42%
5-Year Return -98.41%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 46.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 04/01/26
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CYAD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 4,700.00%
Debt/Equity 0.03
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -204.05
60-Month Beta 1.86
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.